Neurologic Disorders

Chapter 27 Neurologic Disorders



Central nervous system (CNS) problems can affect many systems and present in a variety of ways and degrees. No other body system has as much influence on a child’s development. The challenge for health care providers is to be able to screen and identify neurologic problems; know when to appropriately refer to specialists; be able to monitor the general health of the patient and provide routine preventive care; serve as a case manager based on school and health care issues; help coordinate resources; and support families as they deal with the challenges of grief and long-term care.



image Anatomy and Physiology



Anatomy


Briefly, the nervous system is divided into two parts: the CNS and the peripheral nervous system (PNS). The CNS consists of the brain and spinal cord. The PNS is made up of a network of afferent nerves and sense organs, which send information to the brain, and the efferent nerves, which send information out to the body for responses. Descending tracts from the brain to the gray matter of the spinal cord include the extrapyramidal tract, which conveys information from the cerebellum to the motor cells of the anterior column, and the pyramidal tract, which is the main motor pathway from the cerebral cortex to the spinal nerves and carries messages for voluntary movement. Most pyramidal tract fibers cross in the medulla, so the left half of the brain controls the right side of the body and vice versa. The anatomic units of the brain and their functions are listed in Table 27-1 and shown in Figures 27-1 and 27-2.


TABLE 27-1 Anatomic Units of the Nervous System and Functions














































































Anatomic Unit Functions
I. Central nervous system  
 A. Brain  
  1. Forebrain—cerebrum  
  a. Cortex (gray matter) Posterior—motor skills
   (1) Frontal area Anterior—decision-making, emotions, memory, judgment, ethics, abstract thinking
Broca’s area—speech
   (2) Parietal area Sensory integration, language, reading, writing, pattern recognition
   (3) Temporal area Memory storage, auditory processing, olfaction, limbic system in deep temporal lobe—arousal
   (4) Occipital area Visual processing
  b. Diencephalon  
   (1) Thalamus Receives and sorts sensory input, modulates motor impulses from cortex
   (2) Hypothalamus Integrates autonomic functions
  2. Midbrain Connects brain with cerebellum, pons, medulla
  3. Hindbrain  
  a. Pons Bridges cerebellum, medulla, midbrain; cranial nerves (CN) V, VI, VIII arise here
  b. Medulla Proximal end of spinal cord; contains reticular system—arousal; CN IX to XII arise here
  c. Cerebellum Coordination and movement; balance; smooth movements
 B. Cranial nerves Sensory and motor components; olfaction; vision; hearing; facial, tongue, pharyngeal, eye, shoulder movements
II. Spinal cord  
 A. Dorsal roots Afferent sensory fibers
 B. Ventral roots Efferent motor fibers
III. Protective layers  
 A. Meninges Protection of delicate nervous tissues
 B. Ventricles  
 C. Cerebrospinal fluid  




Autonomic Nervous System


The visceral activities of the body (i.e., blood vessels, glandular secretions, gastrointestinal tract, cardiac muscle) are controlled by the autonomic nervous system (ANS). The ANS is comprised of the sympathetic system and the parasympathetic system, which are principally under the control of the hypothalamus. When the hypothalamus receives information from the cortical centers (e.g., visual, auditory, olfactory) and sensory stimuli from the various parts of the body (e.g., organs, glands), it functions as a “switchboard” between the two systems. Generally, both systems supply the same organs, glands, and smooth muscles. The sympathetic system begins in the thoracolumbar area of the spinal cord and extends distally; its function is often referred to as the “fight or flight” reaction. It is most active when an individual is physically or mentally stressed. The parasympathetic system begins in the medulla and midbrain with relays to the thalamus and higher centers. Enervation results in slowed activity, a decreased metabolic rate, and the conservation of energy; this system is active when an individual is mentally or physically relaxed. The principal sympathetic system neurotransmitters are epinephrine and norepinephrine. The parasympathetic fibers produce acetylcholine. The two systems function in balance—one excites and the other inhibits (Box 27-1). The enteric system is a component of the ANS, but does not play a role specifically in neurology. This system consists of a meshwork of nerve fibers that innervate the digestive system.





image Pathophysiology and Defense Mechanisms


The nervous system is intimately related to functioning of the entire body; problems in any part of the system can have neurologic implications. Examples include uncontrolled firing of cerebral neurons (seizures); the inability of cerebral neurons to fire or the inability of the CNS to process stimuli and respond accordingly (coma); or the inability of peripheral nerves to respond to or receive signals through the pyramidal system of afferent and efferent nerves (paralysis). Other problems occur when special areas of the nervous system or individual nerves are damaged. Broad incapacity occurs with neurotransmitter problems. Many CNS disorders have interactive genetic, immunologic, and infectious factors that are probably causative (e.g., multiple sclerosis, cerebral palsy). Other causative factors include:



Systemic Problems. The brain is extremely sensitive to changes in physiology anywhere in the body. Thus, any metabolic change, whether from external or internal factors (autoimmune, inflammatory, infectious causes), affects the CNS. Examples include delirium from toxins, diabetic coma, meningitis, epilepsy, ataxias, and chorea.


Neurodegenerative Disorders. Neurodegenerative disorders result from a loss of structure or function of neurons in the brain or spine, including death of neurons. Many neurodegenerative diseases are caused by genetic mutations (e.g., multiple sclerosis, Rett syndrome).


Genetic Problems. Many medical disorders have a genetic component that directly affects the nervous system. Some of the single-gene defects may have direct neurologic effects (such as neurofibromatosis), whereas others, typically inborn errors of metabolism, can have indirect effects via the abnormal metabolites released (e.g., phenylketonuria). Other examples of disorders with a genetic component include Tourette and Rett syndromes.


Structural Defects. Because the CNS is structurally complex, there are many opportunities for defects to occur in utero. Examples of such defects include hydrocephaly, anencephaly, and spina bifida.


Trauma. Head and spinal cord injuries are common and can have long-term, serious consequences for the child. Such complex neurologic tissue does not always heal in a way that results in full recovery of function(s).


Tumors and Cancer. Benign or cancerous tumors evolve when there is a problem with cellular division. Problems with the body’s immune system can also lead to such tumors.


Peripheral nerves can regenerate somewhat if conditions are optimal. In the spinal cord the axons of injured neurons cannot regrow within the cord, but they can grow in peripheral nerves outside the cord. In this case, if the cut ends are reconnected with special attention to the myelin sheath, regeneration of the injured nerve begins at the proximal end of the neuron soon after injury. The growth rate is approximately 2.5 to 3 mm per day (Menkes and Moser, 2006).



image Assessment of the Nervous System


Assessment of the nervous system requires a careful history of the patient and family, and a detailed physical examination. The examiner needs to determine if a neurologic disorder exists and, if so, the disorder’s location and the patterns of impairment. For children with complex or severe neurologic problems, social, environmental, developmental, and family issues need thorough exploration. Historical information from patients more than 3 years old and from one or more family members provides the most accurate picture. Imaging or laboratory studies may be required.



History




History of present illness









Medical history













Family disease history






Developmental history



Functional health



Social context


image Inquire about the family composition (including critical family events such as additions or losses of family members); home, neighborhood, and school environment; culture and ethnicity; other stressors; strengths; resources; childcare; financial issues (socioeconomic status, poverty); identified social supports (e.g., family, friends, health professionals); and community agencies involved with the family and child.


Review all systems plus




Physical Examination


The following should be noted:




Specifics of the Neurologic Examination


The neurologic examination moves from the highest level of functioning to the lowest. Cerebral function is tested first; then cranial nerves, motor function, and sensory function; and finally reflexes. The neonate’s neurologic functioning is largely subcortical. Therefore, the examination is more limited than in an older infant or child. In infants and children, watching them carefully while collecting the history and actively playing with them in an age-appropriate manner provides a great deal of neurologic information. A tennis ball, some small toys (e.g., a small car), a bell, and something that attracts attention (e.g., a pinwheel) are useful throughout the examination.





Motor Examination


Gait, posture, coordination, balance, strength, symmetry, quality of movement, and tone are aspects of the motor examination. Information can be gained from questioning the parent because it is often difficult to elicit the needed skills in the time and environment given.



Muscle strength and size. Look at muscle size, contour, and symmetry. Have the child stand from a lying position. Look for Gower’s sign (i.e., a child using the arms to push off from bent knees and gradually climbing the body and straightening up, which is common in children with muscular dystrophy). Ask the child to move extremities against resistance and to grip your fingers hard. The presence of muscular hypertrophy or hypotrophy should be noted.


Muscle tone. Muscle tone might be considered the resting strength of the muscle. Is the trunk control and/or extremities floppy, rigid, or somewhat stiff when the child is resting or active? How difficult is it to move body parts passively? Tone may be increased or decreased all over or differ between the legs and the trunk and arms.


Fine motor coordination. Fine motor coordination is tested by having the child pick up small pieces, write, stack blocks, copy pictures, turn book pages, put puzzles together, or do other hand activities.


Involuntary movements. Tremors are fine involuntary movements. Chorea or choreiform movements are large, irregular jerking and writhing movements. Athetoid movements are slow writhing movements, especially of the hands and feet. Dystonia is an uncontrolled change in tone with movement and a tendency to hyperextend the joints.


Reflexes. When a reflex is abnormal, the question is, why? Did the impulse not go through, or did the child have a problem in the ability to move responsively because of problems in efferent signals or muscle tissue contractility? (See section on reflexes that follows.)


In an infant, assessing posture and muscle tone is fundamental. Motor testing should include observation for symmetry of movements, consistent fisting of the hands, opisthotonos, scissoring, abnormal tone, and tremors. The infant’s cry can be an indicator of several diseases (e.g., it is high pitched with increased intracranial pressure, resembles mewing in cri du chat syndrome, and is hoarse with hypothyroidism).








Diagnostic Studies




Radiographs have relatively little diagnostic value for the neurologic system since the advent of computed tomography (CT) and magnetic resonance imaging (MRI). CT scans display differences in density of the intracranial tissues and structures. MRI provides additional information related to aneurysms (e.g., hemorrhages, calcifications, abscesses), brain structure, and the cellular activity of various parts of the neurologic system (e.g., tumors, CNS, spinal cord, and malformations). There may be a medical need to order more specific tests, such as a magnetic resonance angiogram (used to detect blood vessel stenosis and aneurysms) or functional magnetic resonance imaging (fMRI—used to detect subtle metabolic changes in the brain that indicate how certain parts of the brain are working). A neurologic consultant can advise when these would be necessary.


Laboratory studies provide indicators of systemic disease, infection, or inflammation. They are especially important for children receiving medication for seizures. Drug levels, liver function, and blood studies may need to be monitored routinely.


Lumbar puncture provides information about metabolism, infections, and trauma.


The electroencephalogram (EEG) provides information about the electrical activity of the CNS, which is important in assessing function rather than structure.


Ultrasonography can be useful in infants to evaluate brain tissue.


Other studies can include polysomnography (helps assess narcolepsy, apnea of infancy, certain movement disorders, and nocturnal seizures); electromyography (tests muscle activity); nerve conduction studies; evoked responses (brainstem—auditory, somatosensory, and visual); electronystagmography (measures eye movements to assess vertigo and postconcussion syndrome); and cerebral arteriography (visualizes cerebral blood vessels to evaluate vascular anomalies and tumors).



image Management Strategies



Counseling


Counseling for neurologic problems involves several components. The family should understand the pathologic condition, including possible etiologies, and the treatment plan; be provided with information about the prognosis with and without treatment and any genetic implications of the diagnosis; and have sufficient time to ask questions about all these issues. Counseling also involves helping families cope with the diagnosis and its short- and long-term implications for the child and family. A plan of care needs to be mutually agreed on and fluid enough to adapt to changes in the child’s condition.


Information about a diagnosis needs to be delivered truthfully, compassionately, and promptly using appropriate terminology. Correct language not only influences how parents relate to their child’s condition but also communicates to others a more accurate reflection of the child’s abilities (e.g., schools, employers). Examples of appropriate terminology include:




Anticipatory Guidance









Specific Neurologic Problems of Children



image Degenerative Disorders


Degenerative disorders consist of a group of neurodegenerative disorders whose etiologies affect either the gray matter or white matter of the brain. Degenerative disorders are believed to be the result of biochemical or metabolic dysfunctions (in turn caused by genetic, immune-mediated demyelination, or by unknown etiologies) that lead to anatomic or functional insults to major portions of the brain. These insults can affect the basal ganglia, cerebellum, brainstem, spinal cord, peripheral and cranial nerves, or cerebrum. Such insults can also follow infections or an altered immune state.


Gray matter diseases involve neurons, and their onset is heralded by seizures, a decrease in cognitive functioning, and visual changes. Gray matter disorders include Menkes syndrome (also called kinky-hair syndrome), progressive infantile poliodystrophy, neuronal ceroid-lipofuscinoses, and Rett syndrome, which is discussed later in the chapter. White matter diseases usually lead to demyelination and are evidenced by decreasing motor skills, ataxia, and spasticity. Such disorders include Schilder disease, acute disseminating encephalomyelitis, acute hemorrhagic leukoencephalitis, and multiple sclerosis (MS) (discussed later). The diagnosis is based on age of onset, clinical features (signs and symptoms), genetic transmission, and chemical and chromosomal studies. It also must be determined if the episodes of disability are single (monophasic) or polyphasic (relapses close to initial onset of symptoms with similar areas of involvement).


In the case of inflammatory demyelination, separate events are determined by whether or not they occur more than 30 days apart and involve separate white matter pathways. In an initial acute demyelinating event it may be difficult to determine a diagnosis; the extent of motor, visual, and neurologic involvement needs to be determined in all events. If a demyelinating event is suspected, the child should be referred to a neurologist (preferably pediatric) for a comprehensive evaluation and diagnosis.



Rett Syndrome


A mutation in the X-linked, methyl-CpG-binding protein 2 gene (MECP2) occurs in 80% of females with classic Rett syndrome features (Percy and Lane, 2009). This gene contains instructions for protein synthesis of methyl cytosine–binding protein. MECP2 is abundant in the brain. When not disabled by mutation, it silences certain genes that control motion and emotion. This neurodevelopmental disorder was previously thought to affect only females and to be lethal to males. However, there has been some reported variation to this X-linked Rett syndrome gene occurring in males that is not lethal and results in mental retardation and neurologic impairment; some have Klinefelter syndrome (XXY) (Percy and Lane, 2009). Defects in MECP2 also occur in patients with autism, schizophrenia, learning disabilities, and neonatal encephalopathy (National Institute of Neurology Disorders and Stroke [NINDS], 2010a). Most females with Rett syndrome represent de novo mutations (Percy and Lane, 2009).


Rather than cause brain degeneration, Rett syndrome arrests maturation of certain areas of the brain. The patient is typically female with an onset of symptoms at 5 to 18 months of age. Those affected cease to gain developmental milestones. CNS irritability and withdrawal develop, and then these girls begin to lose skills, including speech and hand skills. Stereotypic hand movements, slowed head growth leading to microcephaly, autistic-like behavior, dementia, and disorganized breathing and apnea followed by hyperpnea occur. Seizures, scoliosis, and spastic paraparesis and quadriparesis are late developments in the syndrome.


Deoxyribonucleic acid (DNA) tests for the presence of mutations in MECP2 and are typically found to be about 80% accurate in diagnosing children with Rett syndrome (Proud and Elias, 2009). This is likely attributed to the possibility that 20% to 30% of the affected patients inherit only a part of the gene that is affected, and it remains undetected with current laboratory testing.


Physical, occupational, and speech therapies and seizure management are important to preserve functional abilities. As with all neurodevelopmental problems, families need significant support and social services. Life expectancy varies depending on complicating factors, but many live well into middle age (Percy and Lane, 2009). Differential diagnoses include cerebral palsy (CP), autism, psychosis, and other neurodegenerative diseases.



Multiple Sclerosis



Description and Epidemiology


MS occurs in 5% of children before the age of 16 (Banwell, 2009). It is exceptional to have symptoms occur before a child is 10 years old (0.2% to 2% of all cases). Two to three times as many females as males are affected. It is widely believed that MS is an autoimmune inflammatory neurodegenerative disorder of the CNS. Macrophages, activated T-lymphocytes, and other destructive molecules are stimulated by yet not fully understood events. These inflammatory cells cause both CNS demyelination and axon damage within the white brain matter, including the optic nerve. Research is focused on environmental (including geography and living north of 40 degrees latitude), infectious, toxic, immunologic, hormonal, or genetic causes. No specific virus has been isolated, although the most promising agent seems to be the Epstein-Barr virus. Some scientists propose that it is multifactorial (National MS Society, 2010).


Overall the clinical course is variable. The disease is typified by two phases: initial relapse and remittance and secondary progression. The episodes of focal neurologic dysfunction can last weeks or months, followed by partial or complete recovery. The more relapses occur earlier in the disease, the more quickly the progression to irreversible disability. It is recognized that focal inflammation of the brain is active, even during the remission phase, and there seems to be a point of no return for the brain’s coping mechanism. This coping mechanism appears to allow for a degree of adaptation for different types of mechanisms of inflammation that originate from outside the CNS, from target-determined changes in immune cells and microglial activation, and from the accumulation of cortical gray matter lesions. Immunoglobulin G (IgG) antibodies have been found in several acute demyelinating presentations and may be the future characterization of phenotypes (Banwell, 2009). However, once irreversible disability begins, the rate of progression is independent of the frequency of relapses.



Clinical Findings


Symptoms are the same for children as for all other ages. These include (Banwell, 2009):






Management


There are no therapies to slow the disease once the progressive phase has started. Therefore, research is focused on finding therapies to slow the early progression of the disease. Treatment involves exercises—resistance, aerobic, and stretching—and routines that promote agility and speed. The use of corticosteroids during exacerbations is traditional therapy. Intravenous methylprednisone results in a faster resolution of visual disturbances and is a widely used treatment for the pediatric population. Other treatments used in adolescents and adults are immunomodulatory therapies (high-dose, high-frequency interferon or low-frequency interferon and glatiramer acetate, cyclophosphamide, natalizumab, and mitoxantrone); these treatments reduce the frequency of contrast-enhancing lesions (Banwell, 2009). Another treatment under study is the use of intravenous immunoglobulin (IVIG), which is postulated to work by binding to circulating antibodies and preventing them from entering the CNS. Adult data show a favorable response, but the studies in young children are limited (Banwell, 2009). Treatment decisions are not dependent on MRI imaging alone. Tools to monitor subtle changes in abilities are often used, such as the McDonald criteria for multiple sclerosis (Hawkes and Giovannoni, 2010). Continuing research is targeting a variety of the mechanisms and processes of the disease to prevent and treat relapses, alter disease progression, and discover neuroprotective factors.



image Nondegenerative Disorders



Benign Paroxysmal Vertigo


Benign paroxysmal vertigo (BPV) may be incorrectly diagnosed as epilepsy. It typically develops in toddlers (median age 18 months) but rarely occurs after 5 years old. BPV is also a known precursor to the development of migraines later in life (Wilkinson, 2009). The history may include rapid onset of an attack that lasts seconds to minutes; daily attacks that occur in clusters over several days and then may not recur for weeks or months; and a possible history of motion sickness. Symptoms are likely to have resolved by the time the child is examined. The physical examination findings consist of:



One possible diagnostic study involves ice water caloric testing to detect abnormal vestibular function. The clusters of attacks may be managed with diphenhydramine, 5 mg/kg/24 hr (maximum 300 mg/24 hr) PO, IM, IV, or per rectum. Once diagnosis is made, parental reassurance is key. Children may be inappropriately diagnosed as having epilepsy and started on anticonvulsants; attacks will not respond to such drugs.



Cerebral Palsy



Description


The term cerebral palsy is used to designate a mixed group of motor disorders that affect motor function and are caused by static injury to developing brains (Brunstrom and Tilton, 2009). This is a chronic, nonprogressive disorder that impairs control of movement by damaging motor areas in the brain. Symptoms appear within the first few years of life. Depending on the area affected and the extent of damage, children with CP can also have mental impairment (up to 66%); seizures (up to 50%); a lag in growth and development; neurosensory disorders affecting touch, pain, and continence; perceptual disorders; impaired vision and hearing; speech, swallowing, or chewing difficulties; and other learning or emotional difficulties. The degree of brain injury can vary from person to person, and the degree of impairment is not necessarily profound but can vary as well (Brunstrom and Tilton, 2009).


There are three major types of CP: spastic, athetoid (or dyskinetic), and ataxic. Spastic is when the muscles stiffen, causing muscle tightness. Athetoid affects the muscles that enable smooth, coordinated movement and maintain body posture; without this control movement becomes involuntary and purposeless. The ataxic type affects balance and coordination. Children may exhibit varying degrees of involvement and severity; capabilities may improve over time depending on the degree of involvement and treatment. Table 27-3 lists more terms that describe CP.


TABLE 27-3 Terms Used to Describe Cerebral Palsy























































Movement Type Description Associated Impairments
Spastic Inability of a muscle to relax Often evident after 4-6 months; retarded speech; convergent strabismus; toe-walking; flexed elbows; delayed walking until 18-24 months; one third have seizures
Athetoid Inability to control muscle movement (continuous, writhing movements) Infant has difficult feeding as a result of tongue thrust, is initially hypotonic with head lag; increasing tone with rigidity over time; speech delay
Ataxic Problems with balance and coordination Tremors
Body Part Involved
Diplegic Affects both legs more than both arms Most have limited use of legs; can walk often with aids; walk typically “scissor-like” with knees bent in and crisscross over each other
Hemiplegic Affects one side of the body (upper extremity is usually affected more than the lower extremity) Often not detected at birth; right side often more affected than left; 50% develop seizures; growth arrest of affected limb(s); individuals usually able to walk
Tetraplegic/Quadriplegic Affects all four extremities, trunk and head Affects upper extremities more than lower; 50% with grand mal seizures; IQ impairment can be severe; most unable to walk or stand
Specific Problems With Movement or Function
Dystonia Involuntary, slow, sustained muscle contraction Abnormal posture, writhing motion of arms, legs, trunk
Choreic Disorganized tone Uncontrollable jerky movements of toes and fingers
Tremor Involuntary, rhythmic movements of opposing muscles; can affect extremities, head, face, vocal cords, trunk  
Ballismus Violent, jerky movements; may affect only one side of body  
Rigidity Stiffness  


Epidemiology


CP was once believed to be caused only by birth complications (neonatal or perinatal asphyxia or trauma), but the Collaborative Perinatal Project demonstrated that most children with CP were born at term without complicated labors and deliveries (Johnston, 2007). The etiology is unknown in a large percentage of cases. Small-for-gestational-age, low birth-weight (less than 1000 g), or preterm babies (less than 37 weeks of gestation), and multiple births are at greater risk for CP. Complicated labor and delivery, breech presentation, Apgar score of less than 3 at 10 minutes or more; traumatic delivery; microcephaly; exposure to maternal infection (evidenced by chorioamnionitis, inflamed placental membranes, umbilical cord inflammation, foul-smelling amniotic fluid, maternal temperature greater than 100.4° F [38° C] during labor, or urinary tract infection [UTI]); maternal vaginal bleeding (between the sixth and ninth month of pregnancy); severe proteinuria late in pregnancy; maternal hyperthyroidism, mental retardation, and seizures; intracranial hemorrhage; toxemia; preeclampsia; antepartal hemorrhage; postmaturity; fetal distress; maternal stroke; coagulation in the fetus or newborn; and neonatal seizures are considered risk factors (Menkes and Moser, 2006). Other etiologies may include intrauterine drug exposure (e.g., alcohol, cocaine, tobacco, crack cocaine), intrauterine infections (e.g., cytomegalovirus, toxoplasmosis, rubella), and congenital brain malformations. In the U.S. it is estimated that children who acquire CP postnatally account for 10% to 20% of those with the disorder. In such cases, the cause can be attributed to meningitis, encephalitis, head trauma (e.g., secondary to shaken baby syndrome or other abuse, car accidents, falls), and kernicterus (Brunstrom and Tilton, 2009).


The prevalence is 1 to 3 per 1000 live births across many studies. Wilson-Costello and colleagues’ study (2007) showed that the use of antenatal steroids and cesarean deliveries decreased neurodevelopmental impairment, sepsis, severe cranial ultrasound abnormalities, and postnatal steroid use in extremely low-birth-weight infants. This resulted in a decrease in the rate of cerebral palsy from 13% to 5% and a decrease in neurodevelopmental impairment from 35% to 23%.



Clinical Findings




Physical Examination




Skin: Dermatologic signs of syndromes, such as neurofibromatosis, may be present.


Orthopedic examination: Scoliosis, contractures, and dislocated hip may be present.


Neurologic examination: The following may be seen:











Vision and hearing: Visual refractive errors occur in 50% of children; strabismus is found in 33%. Hearing problems may have resulted from the initial brain insult.


Development: Assess gross motor, fine motor, language, and personal social skills. The Denver Developmental Screening Test II (Denver II) can be used for initial screening. Motor milestones are commonly delayed. Note quality of movements (e.g., smoothness of gait, grasping, clarity of speech).


Feeding: Note a reversed swallow wave; uncoordinated suck and swallow; decreased tone of the lips, tongue, and cheeks; increased gag reflex; involuntary tongue and lip movements; increased sensitivity to food stimuli; poor occlusion; and delayed inhibition of the suck reflex.


Evaluate the diet, height, weight, and BMI for adequate nutrition.





Management


The management of children with CP described here can serve as a model for the management of children with a variety of neurologic problems.



Referral of suspected cases. Children with CP should be evaluated and cared for at centers that provide interdisciplinary caregivers, including a developmental pediatrician, gastroenterologist, orthopedist, neurologist, nurse, speech pathologist, physical and occupational therapists, education consultant and psychologist, and social worker. Care may also involve an ophthalmologist, feeding clinic and nutritionist services, and genetics counseling.


Family education about the diagnosis. Families need to understand the diagnosis and its nonprogressive but incurable characteristics. They need to understand that the extent of brain damage is not always related to the extent of disability; no one can predict what the future for a given child will be. Children who receive special services—physical therapy, speech therapy, and other interventions—have better outcomes than children who are left to develop on their own. United Cerebral Palsy has educational materials and a variety of services available.


Family support. Generally, families grieve when given the diagnosis of CP and need support during this time. Support groups or opportunities to meet other families with affected children are often helpful. The emotional needs of siblings must not be overlooked. The social worker can be very helpful to families trying to cope with complex health problems.


Financial resources. CP services are long term and expensive. Many children will be eligible for Supplemental Security Income or state program benefits for the severely handicapped. Respite care may be available. The Individuals with Disabilities Education Act of 1997 (IDEA) requires children with disabilities to be assessed for and instructed in the use of assistive devices along with appropriate referrals to regional centers. Some insurance companies try to avoid the costs of long-term care and therapy. Medical social workers and public health nurses can be very helpful in connecting families to appropriate services.


Nutrition. Children with CP often have inadequate nutrition because of their problems with biting, sucking, chewing, swallowing, and self-feeding. Additionally, children with athetosis may need as much as 50% to 100% more calories to support their increased caloric needs because of their constant writhing movements. Children with spasticity, on the other hand, may need fewer calories because of their decreased movements. Occasionally, the problems are so severe that a gastrostomy is needed, sometimes with fundoplication to prevent reflux and aspiration. Special positioning, feeding therapy, and special feeding devices can help. High nutrient density is a key to providing a nutritious diet (i.e., getting more nutrients into the same volume of food) (also see Chapter 10). Feeding clinics are often helpful.


Elimination. Constipation is common because of lack of exercise, inadequate fluid and fiber intake, medications, poor positioning, low abdominal muscle tone, and other factors. Stool softeners, such as docusate sodium, may help. Laxatives, such as senna concentrate or Milk of Magnesia, may be useful but should not be used long term. Osmotic agents may also be used (e.g., polyethylene glycol). Bladder control and urinary retention are also problems in CP; these children are three times more likely to suffer UTIs (Richardson and Palmer, 2009).


Most children achieve bladder control between 3 and 10 years old. For some, toilet training may be difficult, especially for those with mental retardation.


Dentistry. Orofacial muscle tone can contribute to malocclusion. Problems with oral mobility make daily dental hygiene difficult, leading to more gum disease. The side effects of some seizure medications can include swollen gums and tooth decay. A careful dental care program is necessary (see Chapter 33: Dental Care of Children with Extra Needs).


Drooling. Inability to manage oral secretions results in drooling. Social isolation, wet clothing, skin excoriation, malodorous breath, discomfort, choking, gagging, and aspiration can make these oral secretions a serious problem. The anticholinergic, glycopyrrolate, is approved for use in those 3 to 16 years old with chronic excessive drooling from neurologic conditions. This cherry-flavored oral solution (1 mg/5 mL) is dosed at 0.05 to 1 mg by mouth two or three times daily. Side effects may be problematic (e.g., dry mouth, vomiting, constipation, flushing, urinary retention, and nasal congestion). Clinical improvement in drooling has been demonstrated in up to 78% of children and adolescents who used this drug (Waknine, 2010). Surgical intervention is a last resort and commonly involves removing the submandibular gland or nerves, or cutting or rerouting the salivary duct.


Respiratory. Positioning problems, an increase in gastroesophageal reflux disorder, and difficulty in clearing secretions place children with CP at higher risk for respiratory problems, notably pneumonias (especially from aspiration). The duration of respiratory symptoms with upper respiratory infections (URIs) is increased in these children because they may have congenital paralysis or sleep-related obstruction (Daniel, 2006; Hill et al, 2009). A tracheotomy may be necessary in severe cases of upper airway obstruction or difficulty.


Skin. The skin in sedentary children is more likely to break down and cause decubitus. There is an increased incidence of skin latex allergies with CP (Behrman and Adler, 2008).


Movement and mobility. Positioning and seating, standing, transportation, bathing, dressing, mobility for play and getting to school are important to assess and manage. Occupational and physical therapists are essential to these aspects of care, and families need their help incorporating various strategies into their homes and lifestyles. The goals of therapy are to improve physical conditioning and gain maximal independence in mobility, fine motor activities, self-care, and communication by promoting efficient movement patterns, inhibiting primitive reflexes, and achieving isolated extremity movements. Bracing, postural support and seating systems, adaptive devices, and early intervention programs beginning in infancy are important. Open-front walkers, quadrupedal canes, gait poles, wheelchairs, and motorized wheelchairs are beneficial in helping children explore their environment more efficiently. Although the condition is not progressive in terms of the brain lesion, contractures, scoliosis, dislocated hips, and other deformities can develop if the child is allowed to maintain abnormal positions for long periods; range-of-motion exercises are a long-term need. Orthopedic care may be necessary. Constraint-induced therapy (the use of the more functional side is restricted) can both improve mobility function and sustain function longer than conventional physical therapy in children with CP (Taub et al, 2004).


Medications. Antispasmodic medications (baclofen, tizanidine, diazepam, and dantrolene) may be used to minimize contractures and spasticity. They are appropriate for children needing only a mild decrease in their muscle tone or in those with widespread spasticity. For results, dosages often need to be high, and side effects can result (drowsiness, upset stomach, high blood pressure, and possible liver damage with chronic use).


Botulinum toxin A injections are used to eliminate pain, minimize contractures, delay or prevent surgery, and maximize function (Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society et al, 2010). Although botulinum toxin A has become standard treatment in pediatrics, it is used off-label (NINDS, 2010b). Its use is dependent on the recommendation of—and after a thorough evaluation by—a pediatric physiatrist, pediatric neurologist, or pediatric orthopedic surgeon, and after input of therapists and family. It is injected directly into muscles (sometimes guided by an electromyogram or electrical stimulation). The child may experience mild flulike symptoms and transient worsening of spasticity; for this reason, injections are best followed by physical and occupational therapies that help strengthen the antagonist and agonist muscles (NINDS, 2010b). The dosage administered depends on which muscles are being selected and muscle size. Results are generally seen within 5 to 7 days and last 3 to 4 months. The toxin has been safely used in infants older than 1 month. Resistance can occur because neutralizing antibodies can develop. Therefore, only the smallest possible effective dose must be used, and at least 3 months must lapse between injections. Contraindications include diffuse hypertonia, myasthenia gravis (MG), motor neuron disease, injection into an infected muscle, caution in pregnancy (fetal complications have been seen in animal studies), and caution when it is coadministered with an aminoglycoside or another agent that interferes with neuromuscular transmission (toxin effect can be increased) (Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society et al, 2010). The numerous side effects should be thoroughly understood by care providers.


Communication. With the combined problems of lack of oral-motor control and the high incidence of mental retardation, communication can be a problem. Speech therapy may be of assistance; augmentative devices, such as computers with voices, can allow for language development and communication of needs even without oral speech. Hearing deficits need to be identified and managed by an audiologist.


Vision. Visual acuity, eye tracking, and binocularity are key factors to be assessed by a pediatric ophthalmologist (Brunstrom and Tilton, 2009).


Osteopenia. Individuals with CP are at risk of bone density loss secondary to their inability to ambulate and place weight on their bones. Some medical providers prescribe bisphosphonates off-label to children (NINDS, 2010b).


Pain. Spastic muscles, strain on compensatory muscles, and frequent or irregularly occurring muscle spasms can cause chronic and acute pain. Diazepam, gabapentin, and complementary therapies (distraction, biofeedback, relaxation, therapeutic massage) can help (NINDS, 2010b).


Special Education. Early intervention programs and specialized educational programs through school systems are often beneficial.


Other Treatments. Surgery is used to release contractures or to sever overactivated nerves (called a selective dorsal root rhizotomy). Selective dorsal root rhizotomy (of spinal nerves) plus intrathecal baclofen decrease spasticity and increase range of motion of affected limbs. Intrathecal baclofen uses an implantable pump to deliver the drug, a muscle relaxant. The pump is programmable with an electronic telemetry wand. Pumps have been successfully implanted in children as young as 3 years of age; this treatment has small but significant risks of complications. It is most efficacious in children who have some motor movement control and who have few muscles to treat that are not fixed or rigid (NINDS, 2010b). Intense physical therapy is an instrumental adjunct treatment.


Strength training can help with balance and weakness. Functional electrical stimulation (involves insertion of a microscopic wireless device into specific muscles or nerves) has been used to activate and strengthen muscles in the hand, shoulder, and ankle. It should be regarded as experimental in CP and is used only as an alternative treatment if other treatments fail to relax muscles or relieve pain (NINDS, 2010b).


Alcohol “washes” (injections of alcohol into targeted nerves) are sometimes used. Benefits can last from months to 2 years or more; side effects include significant risk of pain or numbness. Research is moving in the direction of developing chemodenervation techniques that deliver injected antispasmodic medications more precisely to target and relax muscles (NINDS, 2010b).


“Patterning” is a controversial physical therapy (child is taught elementary movements, such as crawling, before advancing to walking skills). The American Academy of Pediatrics and other organizations do not endorse this technique because of the lack of evidence-based studies. Likewise, the Bobath technique (involves inhibiting abnormal movement patterns in favor of more normal ones) has provoked strong reservations about efficacy. Conduction education (use of rhythmic activities combined with physical maneuvers on special equipment) has failed to consistently produce improvement (NINDS, 2010b).

< div class='tao-gold-member'>

Stay updated, free articles. Join our Telegram channel

Jul 24, 2016 | Posted by in PEDIATRICS | Comments Off on Neurologic Disorders

Full access? Get Clinical Tree

Get Clinical Tree app for offline access